Pure Global
NCT06420505

MULTICENTER OBSERVATORY EVALUATING THE POLYMER-FREE SIROLIMUS ELUTING CORONARY STENT SYSTEM VIVO ISAR IN ROUTINE CLINICAL PRACTICE

Multicenter Observatory Evaluating the Polymer-Free Sirolimus Eluting Coronary Stent System VIVO ISAR in Routine Clinical Practice (CELEBRITY Observatory)
Translumina GmbH·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Artery Coronary Stenosis
Drug/Device/Intervention
Percutaneous Coronary Intervention
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Translumina GmbH
Location
Aix-en-Provence,Caen,Colmar,Essey-lès-Nancy,Haguenau,Marseille,Marseille,Massy,Montauban,Nantes,Ollioules,Paris,Quincy-sous-Sénart,Reims,Rouen,Strasbourg,Tarbes,Toulouse,Toulouse, France
Timeline & enrollment
Phase
N/A
Start date
Nov 29, 2023
End date
Jan 01, 2027
Enrollment
3000 participants
Primary outcome

rate of target lesion failure

Summary

The rationale for this observatory is to evaluate clinical outcomes and collect data of the
 Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with
 follow-up at 12 months. All medications and procedures to be used/ performed in this
 observatory are commonly used/performed for clinical indications as part of standard of care
 and have well-defined safety profiles.

ICD-10 classifications
Stenosis of aortaAortic (valve) stenosisStenosis of pulmonary arteryAbnormal findings on diagnostic imaging of heart and coronary circulationAortic (valve) stenosis with insufficiency
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420505
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06420505 through Pure Global AI's free database. This phase not specified trial is sponsored by Translumina GmbH and is currently Recruiting. The study focuses on Artery Coronary Stenosis. Target enrollment is 3000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.